Down-Regulation of HLA Class I Antigen is an Independent Prognostic Factor for Clear Cell Renal Cell Carcinoma

Journal of Urology

Volumn 177, Issue 4, 2007, Pages 1269-1272

  Kitamura, Hiroshi ^a   Honma, Ichiya ^a   Torigoe, Toshihiko ^a   Asanuma, Hiroko ^a   Sato, Noriyuki ^a   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

carcinoma; histocompatibility antigens class I; prognosis; renal cell; survival

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER SIZE; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DOWN-REGULATION; FEMALE; GENES, MHC CLASS I; HLA ANTIGENS; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 33947191443     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.11.082     Document Type: Article

References (16)

1. Motzer R.J., Mazumdar M., Bacik J., Berg W., Amsterdam A., and Ferrara J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17 (1999) 2530
2. Leibovich B.C., Blute M.L., Cheville J.C., Lohse C.M., Frank I., Kwon E.D., et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97 (2003) 1663
3. Sengupta S., Lohse C.M., Cheville J.C., Leibovich B.C., Thompson R.H., Webster W.S., et al. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer 106 (2006) 304
4. Lohse C.M., and Cheville J.C. A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma. Clin Lab Med 25 (2005) 433
5. Steiner T., Knels R., and Schbert J. Prognostic significance of tumour size in patients after tumour nephrectomy for localized renal cell carcinoma. Eur Urol 46 (2004) 327
6. Michael A., and Pandha H.S. Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapies. Lancet Oncol 4 (2003) 215
7. Motzer R.J., Bander N.H., and Nanus D.M. Renal-cell carcinoma. N Engl J Med 335 (1996) 865
8. Khong H.T., and Restifo N.P. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol 3 (2002) 999
9. Atkins D., Ferrone S., Schmahl G.E., Störkel S., and Seliger B. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?. J Urol 171 (2004) 885
10. Kitamura H., Torigoe T., Honma I., Asanuma H., Nakazawa E., Shimozawa K., et al. Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy. Urology 67 (2006) 955
11. Marincola F.M., Jaffee E.M., Hicklin D.J., and Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 74 (2000) 181
12. Brasanac D., Muller C.A., Muller G.A., Hadzi-Dzokic J., and Markovic-Lipkovski J. HLA class I antigens expression in renal cell carcinoma: histopathological and clinical correlation. J Exp Clin Cancer Res 18 (1999) 505
13. Seliger B., Caberrera T., Garrido F., and Ferrone S. HLA class I antigen abnormalities and immune escape by malignant cells. Semin Cancer Biol 12 (2002) 3
14. Beadling C., and Slifka M.K. Quantifying viable virus-specific T cells without a priori knowledge of fine epitope specificity. Nat Med 10 (2006) 1208
15. Koopmann J.O., Hammerling G.J., and Momburg F. Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr Opin Immunol 9 (1997) 80
16. Seliger B., Atkins D., Bock M., Ritz U., Ferrone S., Huber C., et al. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation. Clin Cancer Res 9 (2003) 1721